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he natural history of atopic
disease in early childhood
is poorly defined. Previous
studies in selected children suffer-
ing from atopic dermatitis, food
allergy, or bronchial asthma report
improvements ranging from 26%
to 90%.8,15,17,23 These findings are
based on the follow-up of affected
children, rather than a randomly
selected population. Early accessi-
ble parameters such as family his-
tory (FH) and sex, as well as clinical
findings including time of onset,
coincidence of different atopic
diseases, and severity of the disease
have been suggested to be of pre-
dictive value for the outcome of
atopic dermatitis and bronchial
asthma.
It is of particular interest to find
factors predicting children at high
risk of developing atopy soon after
birth to start preventive programs
in the immediate postnatal period.
Therefore, predictive clinical pa-
rameters of established atopy, like
time of onset,2° number of affected
systems, 4,20 and severity of the
symptoms,23 might be helpful but
are not of great benefit concerning
preventive applications.
In this preliminary report, we
studied prospectively the natural
history of atopy during early child-
hood and investigated whether
cord blood IgE (CB-IgE), FH, and
sex are valuable parameters to pre-
dict the outcome of atopic disease
in early childhood.
Patients and Methods
Two hundred children bom in
Munich at the Klinikum rechts der
Isar der Technischen Universitdt
Munchen and at the Schwabinger
Krankenhaus between September
1984 and February 1985 partici-
pated in the present prospective
study. To ensure feasibility, only
children born between 8 a.m. and
5 p.m. were included, if informed
consent by the parents was ob-
tained.
At birth, cord blood from the
200 newborns was collected.
Serum for CB-IgE determination
was separated and stored at -20°C
until assayed. Total IgE was mea-
sured by an enzyme immunoassay
(Phadezym IgE Prist). All assays
were carried out twice. The lower
limit of sensitivity was 0.25 kU/L.
The coefficient of variation for
intra- and interassay variability was
below 5.5% for values between 0.25
and 13 kU/L. A cut-off level of
greater than 0.9 kU/L was chosen
to distinguish between high and
low CB-IgE concentrations. 14
The parents were asked to answer
questionnaires at the time of the
child’s birth, at 13 months (+ one
month ) , and at three years (+three
months) after birth. At birth, the
FH of possible atopic disease was
obtained in 200 cases. After 13
months and three years, question-
naires were sent to all parents
whose addresses could be traced.
About 80% responded: 144 after
13 months (n=181 ) , 124 after three
years (n=148), 112 at both time
points. Only the data of these 112
children were used for further
analysis. The questions covered the
family history of atopic disease and
the child’s own symptoms since the
birth regarding skin, conjunctiva,
respiratory and gastrointestinal
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tracts. Doubtful answers were
checked by telephone interviews
with the parents as well as the pri-
vate pediatricians and, in addition,
by clinical examination. Without
knowledge of CB-IgE, current IgE
serum levels, or the results of pre-
vious examinations we divided the
children into the groups described
below. The chi-square test was used
in the statistical analyses. P values of
<0.05 were considered significant.
Obvious Atopic Disease
Atopic dermatitis: three or
more basic features, plus three or
more minor features, of the guide-
lines for the diagnosis of atopic
disease by Hanifin and Rajkal (not
used was the feature &dquo;personal or
family history of atopy&dquo;).
Bronchial asthma: three or
more episodes of bronchial ob-
struction, diagnosed at least once
by a pediatrician.l2
Allergic rhinitis: rhinitis and/or
conjunctivitis two or more times
after exposure to a particular aller-
gen and unrelated to infection. 12
Urticaria: acute, generalized ur-
ticaria two or more times after ex-
posure to a particular allergen.12
Food allergy with acute gastroin-
testinal symptoms: any kind of gas-
trointestinal symptom (vomiting,
diarrhea, abdominal pain, or colic)
within two hours after food inges-
tion, verified by elimination and
challenge study of the particular
allergen. 13
To decrease the inevitable mis-
classification of children based
only on symptoms reported by
questionnaires, we exclusively ac-
cepted children as obvious atopic
if their symptoms were indepen-
dently confirmed by two pediatri-
cians who carried out the clinical
examination in this study.
Probable Atopic Disease
Atopic dermatitis: pruritus and
dry, squamous dermatitis.&dquo;
Bronchial asthma: two episodes
of bronchial obstruction at least
once diagnosed by a pediatrician
and/or four or more episodes of
bronchitis, pneumonia, or persis-
tent coughing.’2
Allergic rhinitis: nasal obstruc-
tion, episodes of sneezing more
than five to 10 times in a row, rhi-
norrhea during at least four weeks
unrelated to infection. 21
Food allergy with acute gastroin-
testinal symptoms: four or more
episodes of vomiting, diarrhea, ab-
dominal pain, or colic within two
hours after ingestion of a particu-
lar food.13
Positive Family History of Atopy
Previous or present symp-
toms of bronchial asthma, al-
lergic rhinitis, atopic dermatitis,
or allergic urticaria in first-de-
gree relatives. To verify the ac-
curacy of the answer, we
registered a positive FH only if
it was mentioned in at least two
out of three questionnaires.
Results
Out of the 200 newborns partici-
pating in this study, 110 (55%) were
male, 90 newborns (45%) were female.
In 59 cases ( 29.5 % ) a family history of
atopy was reported. An increased
level of CB I~E (>0.9 kU/L) was de-
termined in 21 infants (10.5%).
During the first year of age, 144
children were available for follow-
up analysis. Nineteen percent de-
veloped an obvious atopy, and 34%
manifested a probable atopic dis-
ease (data not shown). After three
years, 112 children remained in
the study. Out of these, 16% suf-
fered from an obvious atopic con-
dition and 8% from a probable
atopic disorder, while 76% had no
atopic symptoms at three years of
age (Table 1). Dropouts and chil-
dren remaining in the study did
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Table 2
PROBABLE, OR NO ATOPIC AT 3 YEARS
¡ OF AGE IN RELATION TO CORD BLOOD ~~~ (CB-M),
I f:~ ~~~ ~~~~~, ~~~ ~~~
sex, FH, or C&IgE (respectively, p
>0.1).
Children with increased CB-IgE
or a FH of atopy developed obvious
atopic disorders significantly more
often during the first three years of
age (respectively, p <0.025, p <0.01).
Atopy was equally as frequent in
both sexes (p >0.1) (Table 2).
The patterns of the different
atopic disorders determined after
the first and third year are listed in
Table 3. Ninety-six percent of all
one-year-old children with an obvi-
ous atopic disease suffered from
atopic dermatitis alone or in asso-
ciation with other atopic manifes-
tations. In the third year, atopic
dermatitis was still predominant,
but decreased to 61 % of all obvious
cases, while bronchial asthma in-
creased in incidence from 17% to
33%. Urticaria was only observed
in three-year-old children.
Of all children with an obvious
or probable atopy in the first year
of age (n=58), 64% (n=37) recov-
ered at the end of the study. On the
other hand, only 11% (n=10) of
healthy or probable-atopic one-
year-old children (n=88) devel-
oped an obvious atopy during the
next two years (Table 4). It is re-
markable that 70% (n=7) of these
children (n=10) already had a clas-
sification of probable atopic disor-
der at one year of age. Out of all
children who showed obvious
atopic symptoms at any time dur-
ing this three-year study period
(n=34), only three children (9%)
developed the initial signs of atopy
after one year of age.
Regarding the outcome of
atopic diseases, we tested CP~-IgE,
FH, and sex as prognostic parame-
ters. From all obvious or probable
atopic one-year-old infants who
had a normal CB-IgE (CB-IgE <0.9
kU/L) at birth (n=47), 19% (n=9)
had an obvious and 6% (n=3) a
probable atopic disorder at three
years of age. Seventy-five percent
(n=35) had recovered and showed
no further symptoms of atopy. In
contrast, only two children (18%)
with obvious or probable atopy at
one year of age and elevated CB-
IgE at birth became healthy during
the follow-up period, while nine
children (82%) continuously suf-
fered from an obvious ( 55 % ) or
probable (27%) atopic disease
(Table 5). Although we could only
study a small number of atopic
one-year-old patients with elevated
CB-IgE, the association between
CB-IgE and outcome of atopy was
significant (p <0.05).
In this study, the prognosis of
atopy in early childhood was not
influenced by the presence or ab-
sence of a positive FH (p >0.1)
(Table 5).
The outcome of atopy was sig-
nificantly influenced by the sex of
the children. Fifty-two percent of
the boys with an obvious or proba-
ble atopic disease at one year of age
showed continuously obvious or
probable atopic symptoms,
whereas 81 % of the girls recovered
(p <0.001 ) (Table 5).
Discussion
In this preliminary report we
followed 200 newborns from birth
up to three years of age; 112 chil-
dren could be followed over the
whole period.
The observed frequency of
atopy in first-degree relatives and
the frequency of increased CB-IgE
levels are in agreement with previ-
ous reports. 6,14 Our data strongly
support the predictive value of
these two parameters for subse-
quent development of atopy.6,14.16
Atopic disorders are common in
early childhood. In the present
study, the cumulated incidence of
obvious atopy for the first three
years of age was 30%. Previous
studies reported an incidence
ranging from 24% to 34% in the
first two years of life.7°l8 A rather
wide range of numbers is found in
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Table 3
I PATTERN OF ATOM AT 1 ANO 3 YEARS OF AGE
the literature from studies with
longer follow-up periods.l,6,14 This
range might be due to different
criteria and methods used to de-
fine atopy, as well as to differences
in the geographical and social
background of the populations
evaluated. In this study, all diagno-
ses of obvious atopic disease were
confirmed by physical examina-
tion to reduce inevitable misclassi-
fication of symptoms merely based
on questionnaires.
The pattern of atopic manifesta-
tion observed in this preliminary
report is typical for the investigated
age group.22 Atopic dermatitis was
the predominant feature of atopy
during the first and third year of
age. At the third year, the number
of children suffering from bron-
chial asthma and urticaria in-
creased, whereas the prevalence of
atopic dermatitis was diminished.
The natural history of atopic
dermatitis,5,17,23 bronchial asth-
ma,4,g,1O and food allergy2,’ has
been studied only in preselected
populations. There are no studies
on unselected children and few on
the natural history of the overall
picture of atopic disease.22 Our
data suggest that the risk of devel-
oping atopic diseases in early child-
hood is highest during the first
year of age. Out of all children who
developed an obvious atopic al-
lergy at any time in the three-year
study period, over two thirds
showed obvious, and one fifth had
probable, symptoms during the
first year of age. In contrast, less
than 10% of all observed children
developed initial signs of atopy
after one year of age. This is in
agreement with other studies
which report a mean onset of atopy
during the first year of age. 7,17 An
explanation for this finding might
be that the transient IgA deficiency
occurring during the first months
of infancy allows increased intesti-
nal permeability and the access of
ingested allergens to the immune
system
There is an extreme variation in
the literature concerning the out-
come of atopic dermatitis, bron-
chial asthma, and food allergy.
Reports of improvement ranged
between 26% and 90%.r5°1’’°23 Most
studies reported recovery in about
50% of the cases. 5,8-10,19 In our study,
two thirds of all obvious or proba-
ble atopic one-year-old infants re-
covered by three years of age.
Explanations for this variation
might be due to different study de-
signs, as mentioned above.
Since the onset of atopic disease
is most frequent during the first
year of age, parameters to predict
subsequent development of atopic
disease and, more importantly, pa-
rameters to predict the outcome of
the disease should be available as
soon as possible after birth. Cord




blood IgE can be determined im-
mediately after birth. The mea-
surement of IgE is sensitive,
specific, reproducible, and of low
cost. In addition to the well-estab-
lished usefulness of CB-IgE for the
prediction of subsequent develop-
ment of atopic disorders, 6,14,16 our
data support the value of CB-IgE as
a prognostic parameter for the out-
come of atopic disease. Children
with normal CB-IgE recovered sig-
nificantly more frequently than
children with elevated CB-IgE lev-
els during the three-year observa-
tion. However, it is difficult to get
definite evidence regarding the
duration of atopic diseases in child-
hood with the present follow-up
period, since there is the possibility
that healthy children at three years
of age could later drop back into
the atopic disease group. Never-
theless, in our present study CB-
IgE predicts the outcome of atopy
during the first three years of age.
To clarify these results, a multicen-
ter study with a longer follow-up
period is in progress.
It has been suggested that the
prognosis of atopic dermatitis and
bronchial asthma is worse among
children with a positive FH.4 In the
present study, we did not find an
association between FH and the
outcome of atopy. Our findings are
in agreement with Businco et al,5
who concluded from their data
that a positive FH was not a prog-
nostic factor for atopic disease in
childhood.
In this study the prognosis was
affected by the sex of the child.
Girls had a significantly better
prognosis compared with boys.
Previous reports indicate a better
prognosis for boys,19 as well as for
girls, 17 or could not find any differ-
ences between sexes.10
The severity of symptoms at the
onset,4 as well as the association of
several atopic manifestations, 4,19
are claimed by some investigators
to indicate the outcome of atopy.
Other studies have examined sev-
eral other parameters, such as skin
reactivity to allergens,5,9,15 and
total’, 15 and specific IgE, 15 for their
value to predict the prognosis of
atopy, but no correlation was
found.
In summary, the present pro-
spective study in randomly selected
children presents evidence that
the natural history of atopic dis-
ease is usually favorable and that
CB-IgE is a valuable parameter to
predict the outcome of atopic dis-
ease in early childhood. Cord
blood IgE could be useful to select
children at high risk of developing
prolonged atopy for entry into pre-
ventive programs in the immediate
postnatal period. In addition,
knowing CB-IgE levels might be
helpful in determining the inten-
sity of the therapy and need of con-
Table 5
trols by the treating physician. To
confirm the results of this prelimi-
nary report, a multicenter study is
in progress.
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